DSIP vs Ipamorelin
Updated 6 sources
Key differences
- 1Ipamorelin acts through growth hormone release and amplifies an existing sleep mechanism. Guides rate it better for recovery than for anxiety-driven insomnia.
- 2They are usually stacked rather than swapped.
Side by side
Facts from each record, in the same words as their own pages.
| DSIP | Ipamorelin | |
|---|---|---|
| Category |
|
|
| Evidence |
|
|
| FDA status |
|
|
| WADA |
|
|
| Half-life |
|
|
| Routes |
|
|
| Forms |
| Not reported |
| Reported doses |
|
|
| Most cited frequency |
|
|
| Vial sizes |
|
|
| Mixed vial keeps |
|
|
| Protocols on file |
|
|
Doses shown are what sources report, labelled by origin. Not medical advice.
Read each in full
Sources
6 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.
Clinical study1
- Ipamorelin PK-PD (Gobburu 1999)PubMed · checked Oct 23, 2026
Regulatory4
- FDA Briefing Document, PCAC July 23-24, 2026: Emideltide-related bulk drug substancesFDA · checked Oct 23, 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (updated April 22, 2026)FDA (Internet Archive copy) · checked Oct 24, 2026
- Certain bulk drug substances, safety risksFDA · checked Oct 23, 2026
- 503A bulk drug substance categories (May 14, 2026)FDA · checked Oct 23, 2026
Competitor guide1
- Peptides for sleeppeptidesexplorer.com · checked Oct 23, 2026